XML 57 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
Level 1~Investments
 3 Months Ended
Mar. 31, 2018
Investments [Abstract]  
Investments
Net Realized Capital Gains (Losses)
 
Three Months Ended March 31,
(Before tax)
2018
2017
Gross gains on sales
$
19

$
61

Gross losses on sales
(57
)
(46
)
Equity securities [1]
16

—

Net OTTI losses recognized in earnings
—

(1
)
Transactional foreign currency revaluation
1

6

Non-qualifying foreign currency derivatives
(3
)
(7
)
Other, net [2]
(6
)
11

Net realized capital gains (losses)
$
(30
)
$
24


[1]
Effective January 1, 2018, with adoption of new accounting guidance for equity securities at fair value, includes all changes in fair value and trading gains and losses for equity securities.
[2]
Includes gains (losses) on non-qualifying derivatives, excluding foreign currency derivatives, of $(10) and $7, respectively, for the three months ended March 31, 2018 and 2017.
Net realized capital gains and losses from investment sales are reported as a component of revenues and are determined on a specific identification basis. Before tax, net gains (losses) on sales and impairments previously reported as unrealized gains or losses in AOCI were $(38) and $14 for the three months ended March 31, 2018 and 2017, respectively. Proceeds from sales of AFS securities totaled $4.3 billion for the three months ended March 31, 2018 and the three months ended March 31, 2017. Effective January 1, 2018, with adoption of new accounting guidance for equity securities, the proceeds from sales of AFS securities no longer includes equity securities.
The net unrealized gain (loss) on equity securities included in net realized capital gains (losses) related to equity securities still held as of March 31, 2018, was $(14) for the three months ended March 31, 2018. Prior to January 1, 2018, these amounts were included in net unrealized gains (losses) in AOCI.
Recognition and Presentation of Other-Than-Temporary Impairments
The Company will record an other-than-temporary impairment (“OTTI”) for fixed maturities if the Company intends to sell or it is more likely than not that the Company will be required to sell the security before a recovery in value. A corresponding charge is recorded in net realized capital losses equal to the difference between the fair value and amortized cost basis of the security.
The Company will also record an OTTI for those fixed maturities for which the Company does not expect to recover the entire amortized cost basis. For these securities, the excess of the amortized cost basis over its fair value is separated into the portion representing a credit OTTI, which is recorded in net realized capital losses, and the remaining non-credit amount, which is recorded in OCI. The credit OTTI amount is the excess of its amortized cost basis over the Company’s best estimate of discounted expected future cash flows. The non-credit amount is the excess of the best estimate of the discounted expected future cash flows over the fair value. The Company’s best estimate of discounted expected future cash flows becomes the new cost basis and accretes prospectively into net investment income over the estimated remaining life of the security.
Developing the Company’s best estimate of expected future cash flows is a quantitative and qualitative process that incorporates information received from third-party sources along with certain internal assumptions regarding the future performance. The Company's considerations include, but are not limited to, (a) changes in the financial condition of the issuer and the underlying collateral, (b) whether the issuer is current on contractually obligated interest and principal payments, (c) credit ratings, (d) payment structure of the security and (e) the extent to which the fair value has been less than the amortized cost of the security.
For non-structured securities, assumptions include, but are not limited to, economic and industry-specific trends and fundamentals, security-specific developments, industry earnings multiples and the issuer’s ability to restructure and execute asset sales.
For structured securities, assumptions include, but are not limited to, various performance indicators such as historical and projected default and recovery rates, credit ratings, current and projected delinquency rates, loan-to-value ("LTV") ratios, average cumulative collateral loss rates that vary by vintage year, prepayment speeds, and property value declines. These assumptions require the use of significant management judgment and include the probability of issuer default and estimates regarding timing and amount of expected recoveries which may include estimating the underlying collateral value.
Prior to January 1, 2018, the Company recorded an OTTI for certain equity securities with debt-like characteristics if the Company intended to sell or it was more likely than not that the Company was required to sell the security before a recovery in value as well as for those equity securities for which the Company did not expect to recover the entire amortized cost basis. The Company also recorded an OTTI for equity securities where the decline in the fair value was deemed to be other-than-temporary. For further discussion of these policies, see Recognition and Presentation of Other-Than-Temporary Impairments within Note 6 - Investments of Notes to Consolidated Financial Statements included in the Company’s 2017 Form 10-K Annual Report.
Impairments in Earnings by Type
 
Three Months Ended March 31,
 
2018
2017
Credit impairments
$
—

$
1

Intent-to-sell impairments
—

—

Impairments on equity securities
—

—

Total impairments
$
—

$
1


Cumulative Credit Impairments
 
Three Months Ended March 31,
(Before tax)
2018
2017
Balance as of beginning of period
$
(25
)
$
(110
)
Additions for credit impairments recognized on [1]:
 
 
Securities not previously impaired
—

(1
)
Reductions for credit impairments previously recognized on:
 
 
Securities that matured or were sold during the period
4

7

Securities due to an increase in expected cash flows
—

5

Balance as of end of period
$
(21
)
$
(99
)
[1]
These additions are included in the net OTTI losses recognized in earnings in the Condensed Consolidated Statements of Operations.
Available-for-Sale Securities
AFS Securities by Type
 
March 31, 2018
December 31, 2017
 
Cost or
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Non-Credit
OTTI [1]
Cost or
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Non-Credit
OTTI [1]
ABS
$
911

$
6

$
(6
)
$
911

$
—

$
1,119

$
9

$
(2
)
$
1,126

$
—

CDOs
1,145

1

(2
)
1,144

—

1,257

3

—

1,260

—

CMBS
3,334

34

(57
)
3,311

(5
)
3,304

58

(26
)
3,336

(5
)
Corporate
12,550

294

(210
)
12,634

—

12,370

490

(56
)
12,804

—

Foreign govt./govt. agencies
1,076

22

(16
)
1,082

—

1,071

43

(4
)
1,110

—

Municipal
11,052

541

(49
)
11,544

—

11,743

754

(12
)
12,485

—

RMBS
3,064

54

(32
)
3,086

—

2,985

63

(4
)
3,044

—

U.S. Treasuries
2,198

35

(21
)
2,212

—

1,763

46

(10
)
1,799

—

Total fixed maturities, AFS
35,330

987

(393
)
35,924

(5
)
35,612

1,466

(114
)
36,964

(5
)
Equity securities, AFS [2]










907

121

(16
)
1,012

—

Total AFS securities
$
35,330

$
987

$
(393
)
$
35,924

$
(5
)
$
36,519

$
1,587

$
(130
)
$
37,976

$
(5
)
[1]
Represents the amount of cumulative non-credit OTTI losses recognized in OCI on securities that also had credit impairments. These losses are included in gross unrealized losses in AOCI as of March 31, 2018, and December 31, 2017.
[2]
Effective January 1, 2018, with the adoption of new accounting standards for financial instruments, equity securities, AFS were reclassified to equity securities at fair value and are excluded from the table above as of March 31, 2018.
Fixed maturities, AFS, by Contractual Maturity Year
 
March 31, 2018
December 31, 2017

Amortized Cost
Fair Value
Amortized Cost
Fair Value
One year or less
$
1,425

$
1,430

$
1,507

$
1,513

Over one year through five years
5,361

5,414

5,007

5,119

Over five years through ten years
6,499

6,525

6,505

6,700

Over ten years
13,591

14,103

13,928

14,866

Subtotal
26,876

27,472

26,947

28,198

Mortgage-backed and asset-backed securities
8,454

8,452

8,665

8,766

Total fixed maturities, AFS
$
35,330

$
35,924

$
35,612

$
36,964


Estimated maturities may differ from contractual maturities due to security call or prepayment provisions. Due to the potential for variability in payment speeds (i.e. prepayments or extensions), mortgage-backed and asset-backed securities are not categorized by contractual maturity.
Concentration of Credit Risk
The Company aims to maintain a diversified investment portfolio including issuer, sector and geographic stratification, where applicable, and has established certain exposure limits, diversification standards and review procedures to mitigate credit risk. The Company had no investment exposure to any credit concentration risk of a single issuer greater than 10% of the Company's stockholders' equity, other than the U.S. government and certain U.S. government agencies as of March 31, 2018 or December 31, 2017.
Unrealized Losses on AFS Securities
Unrealized Loss Aging for AFS Securities by Type and Length of Time as of March 31, 2018
 
Less Than 12 Months
12 Months or More
Total
 
Amortized Cost
Fair Value
Unrealized Losses
Amortized Cost
Fair Value
Unrealized Losses
Amortized Cost
Fair Value
Unrealized Losses
ABS
$
520

$
515

$
(5
)
$
33

$
32

$
(1
)
$
553

$
547

$
(6
)
CDOs
905

903

(2
)
—

—

—

905

903

(2
)
CMBS
1,701

1,662

(39
)
242

224

(18
)
1,943

1,886

(57
)
Corporate
5,931

5,785

(146
)
1,066

1,002

(64
)
6,997

6,787

(210
)
Foreign govt./govt. agencies
552

539

(13
)
51

48

(3
)
603

587

(16
)
Municipal
2,077

2,044

(33
)
230

214

(16
)
2,307

2,258

(49
)
RMBS
1,448

1,421

(27
)
132

127

(5
)
1,580

1,548

(32
)
U.S. Treasuries
850

838

(12
)
272

263

(9
)
1,122

1,101

(21
)
Total fixed maturities, AFS in an unrealized loss position
13,984

13,707

(277
)
2,026

1,910

(116
)
16,010

15,617

(393
)
Unrealized Loss Aging for AFS Securities by Type and Length of Time as of December 31, 2017
 
Less Than 12 Months
12 Months or More
Total
 
Amortized Cost
Fair Value
Unrealized Losses
Amortized Cost
Fair Value
Unrealized Losses
Amortized Cost
Fair Value
Unrealized Losses
ABS
$
461

$
460

$
(1
)
$
30

$
29

$
(1
)
$
491

$
489

$
(2
)
CDOs
359

359

—

1

1

—

360

360

—

CMBS
1,178

1,167

(11
)
243

228

(15
)
1,421

1,395

(26
)
Corporate
2,322

2,302

(20
)
1,064

1,028

(36
)
3,386

3,330

(56
)
Foreign govt./govt. agencies
244

242

(2
)
51

49

(2
)
295

291

(4
)
Municipal
511

507

(4
)
236

228

(8
)
747

735

(12
)
RMBS
889

887

(2
)
137

135

(2
)
1,026

1,022

(4
)
U.S. Treasuries
658

652

(6
)
254

250

(4
)
912

902

(10
)
Total fixed maturities, AFS
6,622

6,576

(46
)
2,016

1,948

(68
)
8,638

8,524

(114
)
Equity securities, AFS [1]
176

163

(13
)
24

21

(3
)
200

184

(16
)
Total securities in an unrealized loss position
$
6,798

$
6,739

$
(59
)
$
2,040

$
1,969

$
(71
)
$
8,838

$
8,708

$
(130
)

[1]Effective January 1, 2018, with the adoption of new accounting guidance for financial instruments, equity securities, AFS were reclassified to equity securities at fair value and are excluded from the table above as of March 31, 2018.
As of March 31, 2018, AFS securities in an unrealized loss position consisted of 2,629 securities, primarily in the corporate, municipal and commercial real estate sectors, which were depressed primarily due to an increase in interest rates and/or widening of credit spreads since the securities were purchased. As of March 31, 2018, 98% of these securities were depressed less than 20% of cost or amortized cost. The increase in unrealized losses during the three months ended March 31, 2018 was primarily attributable to higher interest rates and wider credit spreads.
Most of the securities depressed for twelve months or more relate to corporate securities and structured securities with exposure to commercial real estate. Corporate securities and commercial real estate securities were primarily depressed because current market spreads are wider than spreads at the securities' respective purchase dates. Certain other corporate securities were depressed because the securities have floating-rate coupons and have long-dated maturities, and current credit spreads are wider than when these securities were purchased. The Company neither has an intention to sell nor does it expect to be required to sell the securities outlined in the preceding discussion.
Mortgage Loans
Mortgage Loan Valuation Allowances
Commercial mortgage loans are considered to be impaired when management estimates that, based upon current information and events, it is probable that the Company will be unable to collect amounts due according to the contractual terms of the loan agreement. The Company reviews mortgage loans on a quarterly basis to identify potential credit losses. Among other factors, management reviews current and projected macroeconomic trends, such as unemployment rates and property-specific factors such as rental rates, occupancy levels, LTV ratios and debt service coverage ratios (“DSCR”). In addition, the Company considers historical, current and projected delinquency rates and property values. Estimates of collectibility require the use of significant management judgment and include the probability and timing of borrower default and loss severity estimates. In addition, cash flow projections may change based upon new information about the borrower's ability to pay and/or the value of underlying collateral such as changes in projected property value estimates.
For mortgage loans that are deemed impaired, a valuation allowance is established for the difference between the carrying amount and estimated fair value. The mortgage loan's estimated fair value is most frequently the Company's share of the fair value of the collateral but may also be the Company’s share of either (a) the present value of the expected future cash flows discounted at the loan’s effective interest rate or (b) the loan’s observable market price. A valuation allowance may be recorded for an individual loan or for a group of loans that have an LTV ratio of 90% or greater, a low DSCR or have other lower credit quality characteristics. Changes in valuation allowances are recorded in net realized capital gains and losses. Interest income on impaired loans is accrued to the extent it is deemed collectible and the borrowers continue to make payments under the original or restructured loan terms. The Company stops accruing interest income on loans when it is probable that the Company will not receive interest and principal payments according to the contractual terms of the loan agreement. The Company resumes accruing interest income when it determines that sufficient collateral exists to satisfy the full amount of the loan principal and interest payments and when it is probable cash will be received in the foreseeable future. Interest income on defaulted loans is recognized when received.
As of both March 31, 2018 and December 31, 2017, commercial mortgage loans had an amortized cost and carrying value of $3.2 billion, with a valuation allowance of $1.
As of both March 31, 2018 and December 31, 2017, the carrying value of mortgage loans that had a valuation allowance was $24. There were no mortgage loans held-for-sale as of March 31, 2018 or December 31, 2017. As of March 31, 2018, the Company had an immaterial amount of mortgage loans that have had extensions or restructurings other than what is allowable under the original terms of the contract.
The following table presents the activity within the Company’s valuation allowance for mortgage loans. These loans have been evaluated both individually and collectively for impairment. Loans evaluated collectively for impairment are immaterial.
Valuation Allowance Activity
 
2018
2017
Balance, as of January 1
$
(1
)
$
—

Reversals
—

—

Deductions
—

—

Balance, as of March 31
$
(1
)
$
—


The weighted-average LTV ratio of the Company’s commercial mortgage loan portfolio was 51% as of March 31, 2018, while the weighted-average LTV ratio at origination of these loans was 61%. LTV ratios compare the loan amount to the value of the underlying property collateralizing the loan. The loan collateral values are updated no less than annually through reviews of the underlying properties. Factors considered in estimating property values include, among other things, actual and expected property cash flows, geographic market data and the ratio of the property's net operating income to its value. DSCR compares a property’s net operating income to the borrower’s principal and interest payments. As of March 31, 2018 and December 31, 2017, the Company held no delinquent commercial mortgage loans past due by 90 days or more.
Commercial Mortgage Loans Credit Quality
 
March 31, 2018
December 31, 2017
Loan-to-value
Carrying Value
Avg. Debt-Service Coverage Ratio
Carrying Value
Avg. Debt-Service Coverage Ratio
Greater than 80%
$
—

0.00x
$
18

1.27x
65% - 80%
265

1.95x
265

1.95x
Less than 65%
2,956

2.78x
2,892

2.76x
Total commercial mortgage loans
$
3,221

2.71x
$
3,175

2.69x

Mortgage Loans by Region
 
March 31, 2018
December 31, 2017
 
Carrying Value
Percent of Total
Carrying Value
Percent of Total
East North Central
$
251

7.8
%
$
251

7.9
%
Middle Atlantic
272

8.4
%
272

8.6
%
Mountain
31

1.0
%
31

1.0
%
New England
292

9.1
%
293

9.2
%
Pacific
828

25.7
%
760

23.9
%
South Atlantic
693

21.5
%
710

22.4
%
West North Central
148

4.6
%
149

4.7
%
West South Central
277

8.6
%
278

8.7
%
Other [1]
429

13.3
%
431

13.6
%
Total mortgage loans
$
3,221

100.0
%
$
3,175

100.0
%
[1]
Primarily represents loans collateralized by multiple properties in various regions.
Mortgage Loans by Property Type
 
March 31, 2018
December 31, 2017
 
Carrying Value
Percent of Total
Carrying
Value
Percent of Total
Commercial
 
 
 
 
Industrial
$
830

25.8
%
$
817

25.7
%
Multifamily
1,043

32.4
%
1,006

31.7
%
Office
749

23.3
%
751

23.7
%
Retail
365

11.2
%
367

11.5
%
Other
234

7.3
%
234

7.4
%
Total mortgage loans
$
3,221

100.0
%
$
3,175

100.0
%

Mortgage Servicing
The Company originates, sells and services commercial mortgage loans on behalf of third parties and recognizes servicing fees income over the period that services are performed. As of March 31, 2018, under this program, the Company serviced commercial mortgage loans with a total outstanding principal of $1.5 billion, of which $581 was serviced on behalf of third parties, $652 was retained and reported in total investments and $225 was reported in assets held for sale on the Company's Condensed Consolidated Balance Sheets . As of December 31, 2017, the Company serviced commercial mortgage loans with a total outstanding principal balance of $1.3 billion, of which $402 was serviced on behalf of third parties, $566 was retained and reported in total investments and $356 was reported in assets held for sale on the Company's Consolidated Balance Sheets. Servicing rights are carried at the lower of cost or fair value and were zero as of March 31, 2018 and December 31, 2017, because servicing fees were market-level fees at origination and remain adequate to compensate the Company for servicing the loans.
Variable Interest Entities
The Company is engaged with various special purpose entities and other entities that are deemed to be VIEs primarily as an investor through normal investment activities but also as an investment manager.
A VIE is an entity that either has investors that lack certain essential characteristics of a controlling financial interest, such as simple majority kick-out rights, or lacks sufficient funds to finance its own activities without financial support provided by other entities. The Company performs ongoing qualitative assessments of its VIEs to determine whether the Company has a controlling financial interest in the VIE and therefore is the primary beneficiary. The Company is deemed to have a controlling financial interest when it has both the ability to direct the activities that most significantly impact the economic performance of the VIE and the obligation to absorb losses or right to receive benefits from the VIE that could potentially be significant to the VIE. Based on the Company’s assessment, if it determines it is the primary beneficiary, the Company consolidates the VIE in the Company’s Condensed Consolidated Financial Statements.
Consolidated VIEs
As of March 31, 2018 and December 31, 2017, the Company did not hold any securities for which it is the primary beneficiary.
Non-Consolidated VIEs
The Company, through normal investment activities, makes passive investments in limited partnerships and other alternative investments. For these non-consolidated VIEs, the Company has determined it is not the primary beneficiary as it has no ability to direct activities that could significantly affect the economic performance of the investments. The Company’s maximum exposure to loss as of March 31, 2018 and December 31, 2017 was limited to the total carrying value of $967 and $920 which are included in limited partnerships and other alternative investments in the Company's Condensed Consolidated Balance Sheets. As of March 31, 2018 and December 31, 2017, the Company has outstanding commitments totaling $711 and $787, respectively, whereby the Company is committed to fund these investments and may be called by the partnership during the commitment period to fund the purchase of new investments and partnership expenses. These investments are generally of a passive nature in that the Company does not take an active role in management. For further discussion of these investments, see Equity Method Investments within Note 6 - Investments of Notes to Consolidated Financial Statements included in the Company’s 2017 Form 10-K Annual Report.
In addition, the Company also makes passive investments in structured securities issued by VIEs for which the Company is not the manager. These investments are included in ABS, CDOs, CMBS and RMBS in the Available-for-Sale Securities table and fixed maturities, FVO, in the Company’s Condensed Consolidated Balance Sheets. The Company has not provided financial or other support with respect to these investments other than its original investment. For these investments, the Company determined it is not the primary beneficiary due to the relative size of the Company’s investment in comparison to the principal amount of the structured securities issued by the VIEs, the level of credit subordination which reduces the Company’s obligation to absorb losses or right to receive benefits and the Company’s inability to direct the activities that most significantly impact the economic performance of the VIEs. The Company’s maximum exposure to loss on these investments is limited to the amount of the Company’s investment.
Securities Lending, Repurchase Agreements and Other Collateral Transactions
The Company enters into securities financing transactions as a way to earn additional income or manage liquidity, primarily through securities lending and repurchase agreements.
Securities Lending
Under a securities lending program, the Company lends certain fixed maturities within the corporate, foreign government/government agencies, and municipal sectors as well as equity securities to qualifying third-party borrowers in return for collateral in the form of cash or securities. For domestic and non-domestic loaned securities, respectively, borrowers provide collateral of 102% and 105% of the fair value of the securities lent at the time of the loan. Borrowers will return the securities to the Company for cash or securities collateral at maturity dates generally of 90 days or less. Security collateral on deposit from counterparties in connection with securities lending transactions may not be sold or re-pledged, except in the event of default by the counterparty, and is not reflected on the Company’s Condensed Consolidated Balance Sheets. Additional collateral is obtained if the fair value of the collateral falls below 100% of the fair value of the loaned securities. The agreements provide the counterparty the right to sell or re-pledge the securities loaned. If cash, rather than securities, is received as collateral, the cash is typically invested in short-term investments or fixed maturities and is reported as an asset on the Company's Condensed Consolidated Balance Sheets. Income associated with securities lending transactions is reported as a component of net investment income in the Company’s Condensed Consolidated Statements of Operations.
Repurchase Agreements
From time to time, the Company enters into repurchase agreements to manage liquidity or to earn incremental income. A repurchase agreement is a transaction in which one party (transferor) agrees to sell securities to another party (transferee) in return for cash (or securities), with a simultaneous agreement to repurchase the same securities at a specified price at a later date. These transactions generally have a contractual maturity of ninety days or less. Repurchase agreements include master netting provisions that provide both counterparties the right to offset claims and apply securities held by them with respect to their obligations in the event of a default. Although the Company has the contractual right to offset claims, the Company's current positions do not meet the specific conditions for net presentation.
Under repurchase agreements, the Company transfers collateral of U.S. government and government agency securities and receives cash. For repurchase agreements, the Company obtains cash in an amount equal to at least 95% of the fair value of the securities transferred. The agreements require additional collateral to be transferred when necessary and provide the counterparty the right to sell or re-pledge the securities transferred. The cash received from the repurchase program is typically invested in short-term investments or fixed maturities and is reported as an asset on the Company's Condensed Consolidated Balance Sheets. The Company accounts for the repurchase agreements as collateralized borrowings. The securities transferred under repurchase agreements are included in fixed maturities, AFS with the obligation to repurchase those securities recorded in other liabilities on the Company's Condensed Consolidated Balance Sheets.
From time to time, the Company enters into reverse repurchase agreements where the Company purchases securities and simultaneously agrees to resell the same or substantially the same securities. The agreements require additional collateral to be transferred to the Company when necessary and the Company has the right to sell or re-pledge the securities received. The Company accounts for reverse repurchase agreements as collateralized financing.
Securities Lending and Repurchase Agreements
 
March 31, 2018
December 31, 2017
 
Fair Value
Fair Value

Securities Lending Transactions:
 
 
Gross amount of securities on loan
$
741

$
922

Gross amount of associated liability for collateral received [1]
$
755

$
945

 
 
 
Repurchase agreements:
 
 
Gross amount of recognized liabilities for repurchase agreements
$
171

$
174

Gross amount of collateral pledged related to repurchase agreements [2]
$
174

$
176

[1]
Cash collateral received is reinvested in fixed maturities, AFS and short term investments which are included in the Condensed Consolidated Balance Sheets. Amount includes additional securities collateral received of $4 and $0 million which are excluded from the Company's Condensed Consolidated Balance Sheets as of March 31, 2018 and December 31, 2017, respectively.
[2]
Collateral pledged is included within fixed maturities, AFS and short term investments in the Company's Condensed Consolidated Balance Sheets.
Other Collateral Transactions
The Company is required by law to deposit securities with government agencies in certain states in which it conducts business. As of March 31, 2018 and December 31, 2017, the fair value of securities on deposit was $2.6 billion and $2.5 billion, respectively.
As of March 31, 2018 and December 31, 2017, the Company pledged collateral of $46 and $104, respectively, of U.S. government securities and government agency securities or cash primarily related to certain bank loan participations committed to through a limited partnership agreement. These amounts also include collateral related to letters of credit.
For disclosure of collateral in support of derivative transactions, refer to the Derivative Collateral Arrangements section of Note 7 - Derivative Instruments of Notes to Condensed Consolidated Financial Statements.